<?xml version="1.0" encoding="UTF-8"?>
<p>Cholestasis, a condition involving a decrease in bile flow, is caused by multiple factors, including infection, alcohol, drugs, tumor, and autoimmunity. Cholestasis can cause damage to organelles and cell membranes in hepatocytes and dysfunction in the hepatobiliary system, eventually resulting in symptom manifestation, such as jaundice, xanthoma, and itch [
 <xref rid="B68" ref-type="bibr">68</xref>]. Although antibiotics/antivirals and immunosuppressants are used to treat infectious cholestasis and autoimmune cholestasis, respectively, ursodeoxycholic acid (UDCA) is currently recommended as the primary therapeutic drug to improve clinical symptoms and bile flow [
 <xref rid="B69" ref-type="bibr">69</xref>]. However, the development of drugs to treat cholestasis and prevent its complications is urgently required as the effects of UDCA remain limited.
</p>
